Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s top competitor, Focus on the Family, earned an annual revenue of $99.2M.
International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s smallest competitor is Medical Fitness Association with revenue of $284.9K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Business and Professional People for the Public Interest | - | $3.1M | 31 | - |
| Senior Council | - | $5.0M | 13 | - |
| Healthcare Financial Management Association (hfma) | - | $21.6M | 106 | - |
| FUTURE HEALTHCARE OF AMERICA | - | $3.7M | 98 | - |
| Focus on the Family | - | $99.2M | 909 | - |
| National Hispanic Media Coalition | - | $780,000 | 2 | - |
| Newhouse | - | $1.6M | 30 | - |
| Medical Fitness Association | - | $284.9K | 5 | - |
| Mercy Foundation North | - | $10.0M | 60 | - |
| America's Blood Centers | - | $3.3M | 17 | - |
Zippia gives an in-depth look into the details of International Society for Pharmacoeconomics and Outcomes Research (ISPOR), including salaries, political affiliations, employee data, and more, in order to inform job seekers about International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The employee data is based on information from people who have self-reported their past or current employments at International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The data presented on this page does not represent the view of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and its employees or that of Zippia.
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) may also be known as or be related to INTERNATIONAL SOCIETY FOR, International Society For Pharmacoeconomics And Outcomes Research ..., International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Joshua Friedman.